Regulation of the proteasome: evaluating the lung proteasome as a new therapeutic target.
CONCLUSIONS
Lung diseases are on the second rank worldwide with respect to morbidity and mortality. For most respiratory diseases, no effective therapies exist. Whereas the proteasome has been successfully evaluated as a novel target for therapeutic interventions in cancer, neurodegenerative, and cardiac disorders, there is a profound lack of knowledge on the regulation of proteasome activity in chronic and acute lung diseases.


BACKGROUND
There are various means of how the amount of active proteasome complexes in the cell can be regulated such as transcriptional regulation of proteasomal subunit expression, association with different regulators, assembly and half-life of proteasomes and regulatory complexes, as well as post-translational modifications. It also becomes increasingly evident that proteasome activity is fine-tuned and depends on the state of the cell. We propose here that 20S proteasomes and their regulators can be regarded as dynamic building blocks, which assemble or disassemble in response to cellular needs. The composition of proteasome complexes in a cell may vary depending on tissue, cell type and compartment, stage of development, or pathological context.


CONCLUSIONS
Dissecting the expression and regulation of the various catalytic forms of 20S proteasomes, such as constitutive, immuno-, and mixed proteasomes, together with their associated regulatory complexes will not only greatly enhance our understanding of proteasome function in lung pathogenesis but will also pave the way to develop new classes of drugs that inhibit or activate proteasome function in a defined setting for treatment of lung diseases.
Comprehensive Pneumology Center (CPC), University Hospital , Ludwig-Maximilians University, Helmholtz Zentrum München, Member of the German Center for Lung Research (DZL), Munich, Germany.
Silke
S
Meiners
Ilona Elisabeth
IE
Keller
Nora
N
Semren
Anne
A
Caniard
D000818:Animals; D020134:Catalytic Domain; D004789:Enzyme Activation; D006801:Humans; D008168:Lung / Q000201:enzymology*; D008171:Lung Diseases / Q000188:drug therapy / Q000201:enzymology*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*
D046988:Proteasome Endopeptidase Complex